EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access

Palliative Care Intervention for Patients With End-Stage Liver Disease

Palliative-Care-Intervention für Patient:innen mit Lebererkrankung im Endstadium

Manisha Verma, Victor Navarro, Andrzej Kosinski, Tamar Taddei, Richard Kalman, A Sidney Barritt Iv, Simona Jakab, Marina Serper, Eric Orman, Maya Balakrishnan, Mina Rakoski, Don Rockey und 17 weitere

JAMA Internal Medicine · 01.06.2026 · 186 (6) · 677

DOI: 10.1001/jamainternmed.2026.0571 ↗

Auf einen Blick

Bei 935 Patient:innen mit ESLD verbesserte sich die Lebensqualität nach 3 Monaten in beiden Gruppen. Die von geschulten Hepatolog:innen durchgeführte Palliativversorgung war der Versorgung durch Palliativspezialist:innen nicht unterlegen.

Fragestellung

Ist eine von geschulten Hepatolog:innen durchgeführte Palliativversorgung bei ESLD wirksam im Vergleich zur Palliativversorgung durch Spezialist:innen?

Methode

Vergleichende Cluster-randomisierte Studie in 19 US-Zentren; 4 Palliativvisiten über 3 Monate; Vergleich von geschulten Hepatolog:innen mit Palliativspezialist:innen.

Ergebnisse

QoL verbesserte sich in beiden Gruppen (hepatologist: 8,01 [95 %-KI 5,38 bis 10,65]; consultative: 7,02 [95 %-KI 4,34 bis 9,71]). Die Nichtunterlegenheit war erreicht (mittlere Differenz 0,98 [95 %-KI −2,86 bis 4,83]).

Schlussfolgerung der Autor:innen

Die Palliativversorgung durch geschulte Hepatolog:innen war mit der durch Palliativspezialist:innen vergleichbar und mit stärkerer Patientenzufriedenheit verbunden.

Kernaussagen

  • QoL verbesserte sich in beiden Gruppen nach 3 Monaten
  • Nichtunterlegenheit der Hepatolog:innen war gezeigt
  • Patientenzufriedenheit stieg in der Hepatolog:innen-Gruppe stärker

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JAMA Internal Medicine, erschienen am 01.06.2026. Verfasst von Manisha Verma und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Jefferson Einstein Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania. Hauptthemen laut MEDLINE: Palliative Care, End Stage Liver Disease, Quality of Life, Gastroenterologists. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Palliative care improves quality of life (QoL) in advanced illnesses, but data in end-stage liver disease (ESLD) are limited. It is unknown whether palliative care delivered by hepatologists is effective when compared with palliative care specialists.

Objective

To compare the effectiveness of palliative care delivered by trained hepatologists with the care delivered by conventional palliative care specialists in improving QoL at 3 months. Design, Setting, and Participants This comparative effectiveness cluster randomized trial for US patients treated for ESLD in 19 US medical centers compared a palliative care intervention delivered by palliative care–trained hepatologists (hepatologist group; 11 centers) with palliative care specialists (consultative group; 8 centers). Eligible patients were US adults with either decompensated cirrhosis or hepatocellular cancer who had a life expectancy of at least 6 months, had not received or scheduled liver transplantation, or had not received palliative care in the prior 3 months. Hepatologists in hepatologist group alone received primary palliative care training. Data collection occurred from January 2019 through June 2025; analysis was conducted from July to September 2025.

Intervention

Participants received 4 palliative care visits over 3 months delivered by either palliative care–trained hepatologists or palliative care specialists, using a structured palliative care checklist. Main Outcomes and Measures Superiority or a priori noninferiority of the effect of palliative care delivered by hepatologists vs palliative care specialists on change in QoL at 3 months, measured by the Functional Assessment of Cancer Therapy-Hepatobiliary (FACT-Hep) total score (higher scores indicating better QoL). Secondary outcomes included change in symptom burden, distress, depression, satisfaction from baseline to 3 months, and mortality.

Results

A total of 935 patients were enrolled (mean [SD] age, 63.0 [10.3] years; 275 female [29%]; 130 Hispanic ethnicity [14%]; 144 Black [15%], 736 White [79%]). From baseline to 3 months, QoL improved in both groups (adjusted mean: hepatologist, 8.01 [95% CI, 5.38 to 10.65]; consultative, 7.02 [95% CI, 4.34 to 9.71]; both P < .001). Although superiority was not found in change in QoL, prespecified noninferiority analysis showed that the improvement in the hepatologist group was noninferior to the consultative group (adjusted mean difference, 0.98 [95% CI, −2.86 to 4.83]; P = .01). Symptom burden (adjusted mean difference, −7.52 [95% CI, −9.89 to −5.15] vs −5.31 [95% CI, −7.60 to −3.03]) and depression (adjusted mean difference, −1.18 [95% CI, −1.78 to −0.57] vs −0.90 [95% CI, −1.49 to −0.31]) improved in both groups, without significant between-group differences. Patient satisfaction improved more in the hepatologist group compared with the palliative care group (adjusted mean difference, 3.37 [95% CI, 2.24 to 4.49] vs 0.91 [95% CI, −0.15 to 1.96]; P = .002). Mortality at 3 months was similar in both groups. Conclusions and Relevance This cluster trial found that palliative care delivered by trained hepatologists was comparable with palliative care delivered by palliative care specialists in improving QoL in patients with ESLD and was associated with greater improvement in patient satisfaction, demonstrating the effectiveness among enrolled patients. Trial Registration ClinicalTrials.Gov Identifier: NCT03540771

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Palliative CareEnd Stage Liver DiseaseQuality of LifeGastroenterologistsHumansFemaleMaleMiddle AgedAgedUnited States

Autor:innen und Institutionen

  • Department of Medicine, Jefferson Einstein Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Duke Clinical Research Institute and Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Duke University, Durham, North Carolina.
  • Department of Medicine, Yale University, Connecticut.
  • Department of Medicine, University of North Carolina, Chapel Hill.
  • Department of Medicine, West Haven VA Medical Center, West Haven, Connecticut.
  • Department of Medicine, University of Pennsylvania, Philadelphia.

Zitieren

APA

Verma, M., Navarro, V., Kosinski, A., Taddei, T., Kalman, R., Barritt Iv, A. S., Jakab, S., Serper, M., Orman, E., Balakrishnan, M., Rakoski, M., Rockey, D., Hunt, K., Cabrera, R., Aytaman, A., John, B., Baffy, G., Nathan, R., Tapper, E., …, & Volk, M. (2026). Palliative Care Intervention for Patients With End-Stage Liver Disease. JAMA Internal Medicine, 186(6), 677. https://doi.org/10.1001/jamainternmed.2026.0571

Vancouver

Verma M, Navarro V, Kosinski A, Taddei T, Kalman R, Barritt Iv AS, et al. Palliative Care Intervention for Patients With End-Stage Liver Disease. JAMA Internal Medicine. 2026;186(6):677. doi:10.1001/jamainternmed.2026.0571

BibTeX
@article{Verma2026,
  author = {Verma, Manisha and Navarro, Victor and Kosinski, Andrzej and Taddei, Tamar and Kalman, Richard and Barritt Iv, A Sidney and Jakab, Simona and Serper, Marina and Orman, Eric and Balakrishnan, Maya and Rakoski, Mina and Rockey, Don and Hunt, Kristel and Cabrera, Roniel and Aytaman, Ayse and John, Binu and Baffy, Gyorgy and Nathan, Rohit and Tapper, Elliot and Roytman, Marina and McGuire, Brendan and Hoppmann, Nicholas and Woodrell, Christopher and Bakitas, Marie and Yue, Yang and Reeve, Bryce and Lin, Li and Tantala, Rebecca and Volk, Michael},
  title = {Palliative Care Intervention for Patients With End-Stage Liver Disease},
  journal = {JAMA Internal Medicine},
  year = {2026},
  volume = {186},
  number = {6},
  pages = {677},
  doi = {10.1001/jamainternmed.2026.0571}
}
Kostenlos starten →